Cynthia M. Butitta, Chief Operating Officer at Kite Pharma, Inc. (KITE), sold 7,050 shares at $100.54 ($711K) on 2017-06-23, disclosed to the SEC on 2017-06-27.
Open-market sale of $711k KITE by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $100.54 | 2,950 | $297K | 41.7% |
| 2 | $101.19 | 2,050 | $207K | 29.2% |
| 3 | $101.19 | 2,050 | $207K | 29.2% |
| Total | $100.92 avg | 7,050 | $711K | 100% |
| Filing → |
| KITE | SELL | 2017-07-11 | $1.5M | — | Filing → |
| KITE | SELL | 2017-06-12 | $885K | — | Filing → |
| KITE | SELL | 2017-04-27 | $2.5M | — | Filing → |